BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22841780)

  • 1. An examination of liver offers to candidates on the liver transplant wait-list.
    Lai JC; Feng S; Roberts JP
    Gastroenterology; 2012 Nov; 143(5):1261-1265. PubMed ID: 22841780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List.
    Hsu EK; Shaffer ML; Gao L; Sonnenday C; Volk ML; Bucuvalas J; Lai JC
    Gastroenterology; 2017 Oct; 153(4):988-995. PubMed ID: 28711630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Declined Offers of Deceased Donor Kidney Allograft and Outcomes in Kidney Transplant Candidates.
    Husain SA; King KL; Pastan S; Patzer RE; Cohen DJ; Radhakrishnan J; Mohan S
    JAMA Netw Open; 2019 Aug; 2(8):e1910312. PubMed ID: 31469394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability in acceptance of organ offers by pediatric transplant centers and its impact on wait-list mortality.
    Mitchell E; Loomes KM; Squires RH; Goldberg D
    Liver Transpl; 2018 Jun; 24(6):803-809. PubMed ID: 29506323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ; Lai JC; Dodge JL; Roberts JP
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations Among Different Domains of Quality Among US Liver Transplant Programs.
    Brown CS; Waits SA; Englesbe MJ; Sonnenday CJ; Sheetz KH
    JAMA Netw Open; 2021 Aug; 4(8):e2118502. PubMed ID: 34369991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates.
    Sharma P; Schaubel DE; Gong Q; Guidinger M; Merion RM
    Hepatology; 2012 Jan; 55(1):192-8. PubMed ID: 21898487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wait-list mortality of young patients with Biliary atresia: Competing risk analysis of a eurotransplant registry-based cohort.
    van der Doef HPJ; van Rheenen PF; van Rosmalen M; Rogiers X; Verkade HJ;
    Liver Transpl; 2018 Jun; 24(6):810-819. PubMed ID: 29377411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of whole-organ in lieu of split-liver transplantation over the last decade: Children experienced increased wait time and death.
    Valentino PL; Emre S; Geliang G; Li L; Deng Y; Mulligan D; Rodriguez-Davalos MI
    Am J Transplant; 2019 Nov; 19(11):3114-3123. PubMed ID: 31152483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation in the United Kingdom.
    Neuberger J
    Liver Transpl; 2016 Aug; 22(8):1129-35. PubMed ID: 27081833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.
    Wong RJ; Gish RG; Ahmed A
    Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
    Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW
    Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreasing mortality and disease severity in hepatitis C patients awaiting liver transplantation in the United States.
    Kwong A; Kim WR; Mannalithara A; Heo NY; Udompap P; Kim D
    Liver Transpl; 2018 Jun; 24(6):735-743. PubMed ID: 29125676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation in Spain.
    de la Rosa G; Fondevila C; Navasa M
    Liver Transpl; 2016 Sep; 22(9):1259-64. PubMed ID: 27197947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
    Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
    J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Analysis of Free-Text Refusals as an Indicator of Readiness to Accept Organ Offers in Liver Transplantation.
    Ge J; Ku E; Roll GR; Lai JC
    Hepatol Commun; 2022 May; 6(5):1227-1235. PubMed ID: 34783178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the Liver Transplant Waiting List in Our Center.
    Emek E; Yesim Kara Z; Demircan FH; Serin A; Yazici P; Sahin T; Tokat Y; Bozkurt B
    Transplant Proc; 2019 Sep; 51(7):2413-2415. PubMed ID: 31474297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes After Declining a Steatotic Donor Liver for Liver Transplant Candidates in the United States.
    Jackson KR; Bowring MG; Holscher C; Haugen CE; Long JJ; Liyanage L; Massie AB; Ottmann S; Philosophe B; Cameron AM; Segev DL; Garonzik-Wang J
    Transplantation; 2020 Aug; 104(8):1612-1618. PubMed ID: 32732838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Wait-List Mortality Between Cholangiocarcinoma and Hepatocellular Carcinoma Liver Transplant Candidates.
    Ziogas IA; Hickman LA; Matsuoka LK; Izzy M; Montenovo MI; Rega SA; Feurer ID; Alexopoulos SP
    Liver Transpl; 2020 Sep; 26(9):1112-1120. PubMed ID: 32475062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival benefit of accepting livers from deceased donors over 70 years old.
    Haugen CE; Bowring MG; Holscher CM; Jackson KR; Garonzik-Wang J; Cameron AM; Philosophe B; McAdams-DeMarco M; Segev DL
    Am J Transplant; 2019 Jul; 19(7):2020-2028. PubMed ID: 30614634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.